Track NKGen Biotech- Warrants (01/09/2028)'s total assets ($16M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest total assets for NKGNW is $16M as of March 2025. That compares with $27M in the prior-year period — down 40.7% year over year. Investors often review this figure alongside NKGen Biotech- Warrants (01/09/2028)'s historical trend and sector peers before judging valuation or financial health.
Over the past year, NKGNW's total assets moved from $27M to $16M — a 40.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in NKGen Biotech- Warrants (01/09/2028)'s operating scale or balance-sheet position.
A total assets figure of $16M for NKGNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting NKGNW's total assets ($16M), review year-over-year change from $27M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.